This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Clinical Insider
Clinical Insider

Flatiron Health has teamed with US cancer care advocacy group to make trials more accessible

Posted by on 21 May 2024
Share this article

Under the agreement the Association of Cancer Care Centers (ACCC) – a network of more than 40,000 practitioners at centers across the US – will be able to use Flatiron’s electronic health record and data capture technologies in studies.

Sumanta Pal, chair of ACCC’s Community Oncology Research Institute (ACORI), described the deal as a significant moment for the organization.

“By bringing cutting-edge tech to our community cancer centers, this partnership will make clinical trials more accessible, streamline data management, and help us deliver improved care to our patients across cancer care settings more efficiently and effectively.”

This was echoed by Ivy Altomare, managing director, head of research oncology, clinical research at Flatiron Health, who said “By putting Flatiron Clinical Pipe in the hands of more community cancer care centers, Flatiron and ACCC will enhance ongoing efforts to expand the footprint of cancer research in the community, broadening access to and representativeness of cancer clinical trials.”

Flatiron describes its technology as an “EHR-to-EDC tool” that captures and transfers clinical study structured and unstructured data.

According to Flatiron, when French drug firm Sanofi used the technology it saw an average of one hour of time savings per patient visit on laboratory data alone.

The firm predicted that with the tech ACCC practitioners and member practices will be able to improve efficiency and reduce time and effort of study data capture, enabling them conduct more clinical studies and offer paths to redirect resources to patient care.

ACCC provides education, resources, and tools to the professional oncology community, and serves alongside Flatiron as a member of CancerX, a public-private partnership announced by The White House as a part of the Biden Cancer Moonshot.

Flatiron has been working to build in cancer research for several years. In March 2023, the firm signed a deal to use healthcare data gathered by software firm Lifebit to support cancer drug development.


Share this article

Sign up for Clinical Insider email updates